A B S T R A C T The present studies indicate that accumulation of digoxin by intact human erythrocytes is the result of two processes: binding of digoxin to the erythrocyte membrane and uptake of digoxin across the membrane into the cell. In contrast, accumulation of ouabain by human erythrocytes is entirely attributable to binding of this glycoside to the plasma membrane. Digoxin binding to the erythrocyte membrane involves a single class of binding sites, is a saturable function of the extracellular digoxin concentration, reversible, temperature-sensitive, dependent on the cation composition of the incubation medium, inhibited by other cardioactive steroids, and correlates with the inhibition of erythrocyte potassium influx. Digoxin uptake across the membrane into the cell is also temperature-sensitive and reversible but is a linear function of the extracellular digoxin concentration, not altered by changes in the cation composition of the incubation medium, not inhibited by other cardioactive steroids, and does not correlate with inhibition of erythrocyte potassium influx. Digoxinspecific antibodies can both prevent and reverse effects of digoxin on potassium influx in human erythrocytes by virtue of the capacity of the antibodies to decrease the amount of digoxin that is bound to the erythrocyte membrane. These antibodies also reduce uptake of digoxin across the plasma membrane into the erythrocyte; however, this portion of cellular digoxin is not responsible for the observed inhibition of potassium influx. In the presence of digoxin-specific antibodies, the changes in digoxin binding to the erythrocyte membrane and in digoxin uptake across the membrane into the cell reflect the ability of the antibodies to form complexes with Dr. Butler is the recipient of a Research Career Development
A B S T R A C T The present studies indicate that accumulation of digoxin by intact human erythrocytes is the result of two processes: binding of digoxin to the erythrocyte membrane and uptake of digoxin across the membrane into the cell. In contrast, accumulation of ouabain by human erythrocytes is entirely attributable to binding of this glycoside to the plasma membrane. Digoxin binding to the erythrocyte membrane involves a single class of binding sites, is a saturable function of the extracellular digoxin concentration, reversible, temperature-sensitive, dependent on the cation composition of the incubation medium, inhibited by other cardioactive steroids, and correlates with the inhibition of erythrocyte potassium influx. Digoxin uptake across the membrane into the cell is also temperature-sensitive and reversible but is a linear function of the extracellular digoxin concentration, not altered by changes in the cation composition of the incubation medium, not inhibited by other cardioactive steroids, and does not correlate with inhibition of erythrocyte potassium influx. Digoxinspecific antibodies can both prevent and reverse effects of digoxin on potassium influx in human erythrocytes by virtue of the capacity of the antibodies to decrease the amount of digoxin that is bound to the erythrocyte membrane. These antibodies also reduce uptake of digoxin across the plasma membrane into the erythrocyte; however, this portion of cellular digoxin is not responsible for the observed inhibition of potassium influx. In the presence of digoxin-specific antibodies, the changes in digoxin binding to the erythrocyte membrane and in digoxin uptake across the membrane into the cell reflect the ability of the antibodies to form complexes with INTRODUCTION Previous studies have documented the ability of digoxinspecific antibodies to prevent and to reverse established cellular effects of digoxin (1-6). Watson and Butler (5) reported that digoxin-specific antibodies would prevent completely both the accumulation of ['H]digoxin by human erythrocytes and the associated inhibition of potassium influx. These authors also reported that addition of digoxin-specific antisera to erythrocytes, which had been preincubated with ['H]digoxin, resulted in complete removal of all detectable glycoside during the subsequent 10 min but reversal of the digoxin-induced inhibition of potassium influx was still incomplete as long as 4 h after addition of the antibody. The basis for the delay between the removal of digoxin and restoration of potassium influx was not established but these authors suggested, among other possibilities, that a small fraction of the ['H]digoxin, which was not detectable with their technique, might have been bound with a high affinity to, and released more slowly from, a specific cellular cation transport system than was the majority of the cellular digoxin that was promptly removed by antibody.
The cardiac glycoside, ouabain, is also accumulated by intact human erythrocytes (7) (8) (9) (10) as well as by erythrocyte ghosts (7, 8) . Uptake of ouabain by intact human erythrocytes is attributable to binding of the glycoside to the plasma membrane (9) (10) (11) . This binding is reversible, exhibits a high degree of chemical specificity, can be detected at ouabain concentrations as low as 10-" M, is dependent on the cation composition of the incubation solution, and correlates with inhibition of potassium influx (10) . These observations raise the possibility that
The Journal of Clinical Investigation Volume 52 August 1973*1820-1833 1820 the discrepancy observed by Watson and Butler (5) , between the time course of ['H]digoxin loss from erythrocytes and that of restoration of potassium influx after addition of digoxin-specific antisera, might be attributable to these authors having measured primarily the release of digoxin molecules that were not bound to the erythrocyte plasma membrane and that did not produce inhibition of erythrocyte potassium influx.
In the present study, we explored the accumulation of digoxin by intact human erythrocytes and, when appropriate, compared this accumulation with that of ouabain. We also explored the relation between cellular accumulation of these two glycosides and the inhibition of potassium influx. Finally, we investigated the effect of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes as well as the effect of these antibodies on digoxin-induced alterations in erythrocyte potassium transport.
METHODS
Erythrocytes obtained from normal male and female volunteers (20-31 yr of age) were washed three times in isosmotic choline chloride (pH 7.4). All incubations were performed at 370C unless otherwise specified and the hematocrit of the incubation mixture was 5-10%o. The standard incubation solution had the following composition (millimolars): NaCl, 150; Tris buffer (pH 7.4), 10; glucose, 11.1.
Total glycoside accumulation was measured using the technique described previously (10 The tube and its contents were inverted and placed in a vial containing 20 ml of liquid scintillation solution. When the vial was capped and shaken the supernate passed from the sample into the scintillator and the precipitate remained in the tip of the sample tube. At some time during the incubation, triplicate 100-,ul samples of the incubation mixture were added to 100 ,ul of 10%o perchloric acid, agitated, centrifuged, inverted, and placed in a vial containing liquid scintillation solution.
To measure the release of glycoside molecules, which had been accumulated by the cell, erythrocytes were preincubated at 37°C with the appropriate ['H]glycoside. At the end of the preincubation period the cells were washed three times as rapidly as possible with at least 50 vol of iced incubation medium that contained no glycoside. Washing was performed by alternate centrifugation at 1,500 g for 1 min and resuspension. The cells were then resuspended in fresh incubation medium and, at appropriate times, the total amount of radioactivity present in the cells was determined using the wash technique described in the preceding paragraph.
To measure glycoside binding to the plasma membrane, erythrocytes were added to incubation solutions containing the appropriate ['H]glycoside and mixed thoroughly. At appropriate times, triplicate 100-Id, samples were added to tubes containing 10 ml of iced, distilled water and mixed thoroughly. The resulting hemolysate was then filtered using a Millipore filter (RAWP-02500, Millipore Corp., Bedford, Mass.) and washed three times with 10 ml of iced, distilled water. The filter plus 100 1l of 10% perchloric acid was then added to 20 ml of liquid scintillation solution and radioactivity determined.
To measure the release of glycoside molecules from the erythrocyte membrane, cells were preincubated with the appropriate ['H]glycoside and then washed three times with iced incubation medium. After resuspension in fresh incubation medium, at appropriate times, the amount of radioactivity bound to the cell membrane was determined by the filtration technique described in the preceding paragraph.
When digoxin binding to the erythrocyte membrane was determined on cells incubated with antiserum, the cells were washed three times with at least 50 vol of iced incubation medium before the hemolysis step. This was necessary because it was found that the digoxin-specific antibodies are retained on the filter and thereby, will give falsely high values for ['H]digoxin binding to the erythrocyte membrane if not removed before the filtration step. Appropriate control experiments using the standard incubation solution indicated that addition of these extra washing steps did not alter significantly the values for [3H]digoxin binding. Unless otherwise specified, digoxin-specific antiserum and control antiserum were present in the incubation solutions at a concentration of 0.03 ml antiserum/ml incubation solution. The digoxin-specific antiserum used for the present studies was obtained from a sheep immunized with a digoxin-bovine serum albumin conjugate prepared by the periodate oxidation method (12) (13) (14) ; this serum was denoted S-62 in a previous report by Watson and Butler (5) . Control antiserum was obtained from a sheep (S-301) immunized in a similar manner. with a 1-methyladenosinebovine serum albumin conjugate also prepared by the periodiate oxidation methoc (12) . All sera were heated at 560C for 30 min to inactivate complement, and absorbed three times with washed human erythrocytes to remove heterophile antierythrocyte antibodies.
The volume of counted cells was calculated from the hemoglobin concentration of the incubation mixture and the hematocrit determined on a separate tube containing the incubation solution and erythrocytes at a hematocrit of approximately 25%. The hematocrit was measured using a Drummond microhematocrit centrifuge (Drummond Scientific Co., Broomall, Pa.) and hemoglobin concentration was measured using the cyanmethemoglobin method (15) .
The accumulation of glycoside was calculated from the counts per milliliter cells and the specific activity of glycoside in the incubation medium. The glycoside concentration in the tritiated material supplied by the manufacturer was determined by measuring the binding of radioactivity to the cell membrane in the presence of constant radioactivity and varying concentrations of the appropriate nonradioactive glycoside (10 and placed in a liquid scintillation solution. The volume of cells counted was calculated from the hemoglobin concentration in the incubation mixture and the previously measured hemoglobin content per volume of cells. Erythrocyte sodium and potassium concentrations were determined as described previously (16) , and the incubation solution concentrations were determined at the end of the incubation period. Sodium and potassium concentrations were measured with an Instrumentation Laboratory model 143 flame photometer (Instrumentation Laboratory, Inc., Lexington, Mass.). Initially, the uptake of "K was determined at 0, 15, 30, and 45 min; however, since the uptake was observed to be constant over this period, potassium influx was calculated from samples taken at 0 and 40 min unless otherwise specified. Potassium influx was calculated using the method described by Sachs and Welt (17) and the average of the potassium concentrations in the incubation solutions at the beginning and end of the incubation period. All counts were corrected for decay.
Digoxin Fig. 4 ). A double-reciprocal plot of these data gave a straight line with intercepts on the x-and y-axis that were significantly different from zero (also see Fig. 3 ). As demonstrated previously for ouabain (10) 10-' M nonradioactive digoxin. Fig. 3 illustrates a double-reciprocal plot of the binding of ouabain and of digoxin to the erythrocyte membrane as a function of their respective concentrations. The slope of the line for digoxin was significantly greater than that for ouabain; however, both plots had the same intercept on the y-axis. The concentration at which binding was half-maximal (KB) was 7.8 (±0.9) X 10' M (mean ± SD) for ouabain and 15.0 (+1.3) X 10-M for digoxin. For both glycosides, the value for maximal binding (Bmax) was 18.3±2.4 pmol/ml cells (i.e., approximately 1,000 molecules/cell). These data agree with previous findings that ouabain and digoxin bind to the same site on the erythrocyte membrane, and that the affinity of the membrane for ouabain is greater than that for digoxin (10). Our value for maximal binding is higher than that reported by others (7-9) and as we have discussed previously (10), the major source of this discrepancy is probably attributable to differences in the method for extracting bound radioactivity from the cells, in the composition of the liquid scintillation solution and in the procedure used to correct for variable counting efficiency. At all concentrations of digoxin studied, values for total cellular accumulation were significantly greater than those for binding to the erythrocyte membrane (Fig. 2) . Furthermore, the shape of the curve describing digoxin accumulation as a function of digoxin concentration was different from that obtained for digoxin binding. The values for digoxin accumulation did not plateau at higher digoxin concentrations but instead, increased in a linear fashion (also see Fig. 4 ). Addition of 10' M ouabain to the incubation medium reduced, but did not abolish cellular accumulation of digoxin ( Fig. 2) , and under these conditions there was a linear relation between digoxin accumulation and digoxin concentration. Similar values were obtained when [8H]-digoxin accumulation was measured in the presence of 10' M nonradioactive digoxin. In the presence of 10' M ouabain and using a 10-fold greater digoxin concentration range, there remained a linear relation between digoxin accumulation and digoxin concentration whereas under the same conditions, there was negligible binding of digoxin to the erythrocyte membrane.
The experiments thus far presented, demonstrate that total cellular accumulation of digoxin is significantly greater than binding of digoxin to the erythrocyte membrane. Because the radioactivity which was accumulated in excess of that bound to the erythrocyte membrane was a linear function of the [3H]digoxin concentration in the incubation medium, it may represent binding of digoxin to a site so abundant or with so low an affinity for the glycoside that it cannot be saturated over the range of digoxin concentrations used. However, because this linear component of [3H]-digoxin accumulation was not detected using the filter technique, we have assumed that this component represents uptake of digoxin across the erythrocyte mem- Fig. 5 , glycosidesensitive potassium influx is plotted as a function of glycoside-binding to the erythrocyte membrane. The line describing this relation for digoxin was not significantly different from that for ouabain indicating that although these two glycosides are bound with different affinities, once they have been bound to the cell membrane they are equipotent in their inhibition of potassium influx.
We previously demonstrated that the affinity with which the erythrocyte membrane binds ouabain is increased by addition of sodium ions to the incubation solution and is decreased by addition of potassium ions (10) . We observed similar effects of sodium and potassium on digoxin binding, but observed no effects of these cations on digoxin uptake across the plasma membrane into the cell (Table II) . ouabain was lost (7.1%/h) was significantly greater (P < 0.01) than that at which bound digoxin was lost. The initial loss of total cellular digoxin was so rapid that a substantial amount of digoxin was probably lost from the cells during the sequential washing and resuspension steps used to remove extracellular digoxin before determining the amount of radioactivity accumulated by the cells. To explore this possibility, experiments were done in which the loss of digoxin accumulated by the cells was determined by measuring the appearance of ['H]digoxin in the supernate after centrifuging a portion of incubation mixture at 10,000 g for 10 s. At 37°C there was a rapid appearance of digoxin in the supernate and this process was complete in approximately 6 min. Using this technique the values obtained for the amount of digoxin lost from the cells were significantly greater than those obtained The initial rapid loss of radioactivity from erythrocytes, which had been preincubated with [3H]digoxin (even when the cells were cooled to 4VC), indicates that the values for total cellular accumulation of digoxin are underestimates of the actual amount of digoxin in the cell at the time the sample was taken. Efforts were made to make constant the total time elapsing between the time a sample was taken from the incubation mixture and the time when the supernate was aspirated after the fourth wash (approximately 3 min); however, relatively small differences in the time required to process the samples could result in relatively large differences in the values for radioactivity present in the cell. These qualifications do not apply to our values for glycoside binding to the erythrocyte membrane since the amount of radioactivity lost during the 3 min period required to process the samples was negligible.
It seemed possible that the initial rapid loss of radioactivity, which had been taken up by the cells, might represent the release from the [8H]digoxin of tritium (or a tritiated portion of the molecule) that was able to cross the erythrocyte membrane rapidly. To evaluate this possibility, we tested the ability of the radioactivity, which was lost from the cells during the initial portion of the incubation period, to bind to the membrane of fresh erythrocytes. The results in Table III ['H]digoxin (i.e., radioactivity that had not been previously exposed to erythrocytes). Furthermore, this binding was specific in the sense that it was blocked by the addition of 10-' M ouabain to the incubation medium. Fig. 7 illustrates the effect of digoxin-specific antiserum on the time course of total cellular accumulation of [3H]digoxin by human erythrocytes. Addition of control antiserum to the incubation medium produced no detectable effect on the time course of digoxin accumulation. Digoxin-specific antiserum abolished cellular accumulation of digoxin. Similarly, digoxinspecific antiserum completely blocked binding of [3H]-digoxin to the erythrocyte membrane, while control antiserum had no effect. Potassium influx measured from the same incubation tubes showed a progressive decrease during the incubation period and this decrease was abolished by digoxin-specific antiserum, but not by control antiserum. Fig. 8 illustrates the effect of digoxin-specific antiserum on the time course of the loss of total cellular digoxin that had been accumulated. The initial rapid component was complete by approximately 10 min and was not altered by digoxin-specific antiserum; the slower component, which represents the release of bound digoxin, was significantly more rapid in the presence of digoxin-specific antiserum. In the presence of control antiserum, bound digoxin was lost at a rate of 1.7 (O.1)%/h (mean ±1 SD) and in the presence of digoxin-specific antiserum, the rate was 4.1 (±0.4) %/h. There was no initial rapid increase in potassium influx to correspond to the rapid initial loss of digoxin accumulated by the cells and the accelerated increase in potassium influx that occurred in the presence of digoxin-specific antiserum correlated with the effect of the antiserum on the loss of digoxin from the cell membrane. Erythrocytes were incubated for 3 h in the standard incubation solution at 370C with [3H]digoxin (1.28 X 10-7 M). Control antiserum, digoxin-specific antiserum, or ouabain (10-s M) was added to three of the four tubes. 15 min and 5 h after these additions total cellular digoxin accumulation, the amount of digoxin bound to the cell membrane and potassium influx were determined. Potassium influx was determined over a 20 min period and the mean potassium concentration in the incubation medium used to measure influx was 9.8 mM. Each value represents the mean of five experiments. * Significantly different from the corresponding value determined in standard incubation solution (P < 0.01 using Student's t test [18] ).
t Significantly different from the corresponding value determined in the same incubation medium at 15 min (P < 0.01).
To explore further the mechanism by which digoxinspecific antiserum accelerated the loss of digoxin bound to the erythrocyte membrane, the effects of adding ouabain (10' M) were compared with those produced by adding digoxin-specific antiserum. The initial rapid loss of total cellular digoxin accumulation was not altered detectably by addition of control antiserum, digoxin-specific antiserum, or ouabain (10' M) to the incubation medium. However, both ouabain and digoxinspecific antiserum, but not control antiserum, produced an equivalent increase in the rate of loss of membranebound digoxin. In similar experiments using ['H]ouabain, there was no detectable effect of ouabain (10-' M) on the rate at which radioactivity was lost from the cell membrane. The experimental conditions were then modified as follows: erythrocytes were preincubated with ['H]digoxin for 3 h (37°C) and washed rapidly three times with iced, standard incubation medium (containing no glycoside); the cells were incubated with digoxin-specific antiserum for 20 min (370C) during which time membrane-bound digoxin remains unchanged, but intracellular digoxin passes out of the cells into the incubation solution where it can combine with antibodies( see Figs. 6 and 8 and Table IV) ; the erythrocytes were again washed rapidly three times to remove the antiserum and antibody-bound glycoside and resuspended in the appropriate incubation solutions; total cellular digoxin and membrane-bound digoxin were determined at hourly intervals for the subsequent 4 h. Under these conditions, in the standard incubation medium, the rate at which bound digoxin was lost from the erythrocyte membrane (4.2±0.8%/h) was not significantly different from that in media containing control antiserum (3.7±0.5), digoxin-specific antiserum (4.3±0.6), or ouabain, 10' M (3.9±0.7). Appropriate control experiments indicated that the 20 min incubation with digoxin-specific antiserum significantly increased (P < 0.01) the observed rate at which digoxin was lost when the cells were subsequently incubated in the standard incubation medium or with control antiserum but did not significantly alter values obtained with ouabain or with digoxin-specific antiserum. Fig. 9 illustrates values for cellular digoxin accumulation when digoxin-specific antiserum was added at different times after the incubation began. Addition of digoxin-specific antiserum to the incubation medium produced an initial rapid decrease in total cellular digoxin after which it decreased at a more gradual rate. Furthermore, the values for cellular digoxin accumulation obtained initially after addition of digoxinspecific antiserum were progressively greater as the addition of the antibody was made at later times during the incubation. Determination of digoxin bound to the erythrocyte membrane from these same incubation tubes showed that the initial rapid decrease in cellular radioactivity represented loss of ['H]digoxin, which had been taken up across the membrane into the cell, and that after addition of digoxin-specific antiserum, values for total cellular accumulation of digoxin were not significantly different from those for digoxin bound to the erythrocyte membrane. Addition of control antiserum did not detectably alter total cellular digoxin accumulation or membrane-bound digoxin.
The experiments summarized in Table IV further explore the effects of adding digoxin-specific antiserum to incubation medium containing cells incubated' with [ 'H]digoxin for 3 h. Adding control antiserum to the incubation medium produced no significant change in the values for digoxin accumulation, digoxin binding, or potassium influx determined 15 min and 5 h after the addition was made. 15 min after adding digoxinspecific antiserum to the incubation medium, values for total cellular accumulation of digoxin were significantly lower than corresponding values obtained in the presence of buffer or control antiserum. However, at this time, no significant effect of digoxin-specific antiserum was observed on digoxin binding or on potassium influx. Furthermore, 15 min after adding digoxin-specific antiserum, the value for total cellular accumulation was not significantly different from that for digoxin binding determined on the same cells. 5 h after adding digoxinspecific antiserum, values for digoxin accumulation and digoxin binding were significantly lower than corresponding values obtained after 15 min from the same incubation tube. Values for potassium influx at 5 h were significantly greater than values from the same incubation tube obtained after 15 min. After 5 h, values for total cellular accumulation of digoxin were not significantly different from those for digoxin binding.
In contrast to the effect of digoxin-specific antiserum, 15 min after adding ouabain (10' M) to the incubation medium, values for cellular accumulation and binding of digoxin as well as for potassium influx were not significantly different from corresponding control values. 5 h after adding ouabain, values for total cellular accumulation of digoxin were significantly lower than values from the same incubation tube at 15 min, but were significantly greater (P < 0.01) than values for total accumulation obtained 5 h after adding digoxinspecific antiserum. Values for digoxin binding obtained 15 min after adding ouabain were not significantly different from control values; however, values obtained 5 h after adding ouabain were significantly lower than corresponding control values obtained after 15 min. These values were also significantly lower (P < 0.01) than values for total digoxin accumulation measured on the same incubation tube. Adding ouabain also produced no detectable change in potassium influx at 15 min or at 5 h. After adding digoxin-specific antiserum the magnitude of the decrease in total cellular digoxin accumulation between 15 min and 5 h was similar to that for digoxin binding during the same time period. Similarly, after adding ouabain, the magnitude of the decrease in total cellular digoxin accumulation between 15 min and 5 h was similar to that for Digoxin-Specific Antibodies digoxin binding during the same time period. Furthermore, the magnitude of the decreases in total cellular digoxin accumulation and in digoxin binding produced by digoxin-specific antiserum was similar to that produced by ouabain.
DISCUSSION
The present experiments indicate that digoxin accumulation by intact human erythrocytes is the result of two processes. A portion of the accumulated digoxin appears to be clearly attributable to binding of digoxin molecules to the plasma membrane since this accumulation was detected by incubation of erythrocytes with [ (Table III) and its accumulation was abolished by addition of digoxin-specific antiserum to the incubation medium. These findings indicate that the radioactivity accumulated in excess of that bound to the erythrocyte membrane does not represent the accumulation of tritiated contaminants or of tritiated metabolites of ['H]digoxin and instead, represents uptake of digoxin across the membrane into the cell. One unlikely possibility, which the present studies do not exclude, is that the two processes by which erythrocytes accumulate digoxin reflect the existence of two populations of erythrocytes: one binds digoxin molecules to the erythrocyte membrane and the other takes up digoxin across the plasma membrane into the cell.
Digoxin binding by the erythrocyte membrane reaches a steady state by approximately 80 min and digoxin once bound is lost from the membrane at a relatively slow rate. Digoxin binding is increased by sodium and decreased by potassium in the incubation medium, it is abolished by reducing the temperature to 4'C or by high concentrations of cardioactive steroids, involves a single class of glycoside-binding sites, and correlates with inhibition of erythrocyte potassium influx. Digoxin uptake across the membrane into the cell reaches a steady state in approximately 80 min and the digoxin so accumulated leaves the cell at a relatively rapid rate. Digoxin uptake is not altered by varying the sodium or potassium concentrations in the incubation medium, is reduced, but not abolished by lowering the incubation temperature to 40C, is not affected by either cardioactive or other steroids, is a linear function of the extracellular digoxin concentration, and does not correlate with inhibition of erythrocyte potassium influx.
In contrast to digoxin, ouabain accumulation by intact human erythrocytes can be accounted for entirely by binding of this glycoside to the plasma membrane. As observed previously, ouabain is a more potent inhibitor of erythrocyte potassium influx than is digoxin in the sense that the ouabain concentration at which inhibition of potassium influx is half-maximal is lower than the digoxin concentration required to produce halfmaximal inhibition (19) . The present studies demonstrate that the difference in potency observed for these two agents on erythrocyte potassium influx reflects a difference in the affinity with which they are bound to the cell membrane and that once they are bound to the cell membrane, they are equipotent in terms of inhibition of potassium influx (see Figs. 3 and 5) .' Baker and Willis (9) The data showing that digoxin-specific antiserum will prevent completely accumulation and binding of ['H] digoxin by human erythrocytes and will prevent the effect of digoxin on erythrocyte potassium influx extend and confirm previous observations of Watson and Butler (5) . The present studies also demonstrate that during the initial 15-20 min after addition of digoxinspecific antiserum to cells, which have been preincubated with ['H]digoxin, there is a rapid loss of radioactivity from the cells, but no detectable change in the amount of digoxin bound to the cell membrane or in potassium influx. If the incubation period is allowed to continue, there is a further, relatively slow decrease in cellular radioactivity that represents the release of digoxin bound to the cell membrane and a corresponding increase in potassium influx. Watson and Butler (5) reported a discrepancy between the time course of digoxin release from erythrocytes and that of recovery of digoxin-inhibited potassium influx. As these authors suggested, this apparent discrepancy can be attributed to their experimental conditions being such that they were unable to detect the fraction of cellular digoxin that is responsible for inhibiting potassium influx, i.e., digoxin which is bound to the erythrocyte mexp~rane. Watson ['H]digoxin was moving from the supernate to the cell membrane. In the case of ouabain, there was no significant cellular accumulation of ouabain molecules in excess of those bound to the cell membrane. Therefore, fewer ouabain molecules accumulated in the incubation medium from which they could then bind to the erythrocyte membrane and the observed decrease in the amount of radioactivity bound to the cell membrane more nearly reflected the rate at which ouabain molecules pass from the cell membrane to the incubation medium. That adding ouabain (10-' M) also produced an apparent increase in the rate at which digoxin was released from the cell membrane and that values obtained with ouabain were the same as those obtained with digoxin-specific antiserum is evidence that digoxin-specific antibodies do not "pry" digoxin molecules off the membrane. Furthermore, if erythrocytes were allowed to accumulate and bind [8H]digoxin and then preincubated with digoxin-specific antiserum for 20 min to remove ['H]digoxin which had been taken up across the membrane into the cell, then the rates at which bound digoxin was lost from erythrocytes after they were washed and incubated with buffer or control antiserum were significantly increased (compared with values obtained on cells that were not preincubated with digoxin-specific antiserum) and were the same as the rates for digoxin loss observed in the presence of ouabain or digoxin-specific antiserum. These findings indicate that the apparent acceleration of the loss of digoxin from the erythrocyte membrane and of the recovery of potassium influx produced by digoxin-specific antiserum (Fig. 8) is attributable to the antibodies forming a complex with the ['H]digoxin which was released from the cells during the initial portion of the incubation period and thereby, preventing this [3H] digoxin from binding to the erythrocyte membrane. Additional evidence against the possibility that digoxin-specific antibodies can directly facilitate the release of bound digoxin molecules from the erythrocyte membrane can be obtained from the studies of Smith et al. mentioned previously (20) . Since digoxin-specific antibodies are presumably larger than the glycoside-protein molecules used by Smith et al., they should likewise be unable to reach the glycoside receptor.
Although the present studies indicate that digoxin molecules, which have been taken up across the plasma membrane into the cell can then leave the cell, enter the extracellular solution, bind to the erythrocyte membrane, and inhibit potassium influx, we do not know whether these intracellular digoxin molecules can gain access to the glycoside-binding site directly without first entering the extracellular solution. In fact, we cannot exclude the possibility that digoxin molecules can bind to the erythrocyte membrane only after they have first entered the cell, i.e., that digoxin molecules do not bind directly from the extracellular fluid. Our inability to detect uptake of ouabain across the erythrocyte membrane into the cell argues against, but does not exclude this possibility. Furthermore, Hoffman (21) has reported that strophanthidin, which was incorporated into erythrocyte ghosts at the time of hemolysis, did not inhibit potassium influx, but upon release from the ghosts, it inhibited cation transport in intact erythrocytes when added to the extracellular solutions.
The observed ability of digoxin-specific antibodies to reduce the net amount of ['H]digoxin, which was bound to the cell membrane, and to accelerate the recovery of potassium influx argues against the possibility that the digoxin, which is accumulated in excess of that bound to the cell membrane, actually produces the inhibition of potassium influx and that the recovery of potassium influx, which appears to correlate with the release of bound digoxin from the cell, is actually due to the slow loss of some inhibitory substance whose accumulation is promoted by the digoxin taken up by the cell (5) (see Fig. 8 ). This correlation of the ability of digoxin-specific antiserum to reduce the amount of bound digoxin and to accelerate the recovery of potassium influx also argues against the recovery of potassium influx being due to the reaccumulation of some necessary substance whose depletion was produced by the digoxin molecules that were taken up across the erythrocyte membrane into the cell (5) .
The mechanism by which digoxin-specific antibodies reverse the effects of digoxin on human erythrocytes can be conceptualized by comparing digoxin-specific antiserum and ouabain in terms of their effects on total cellular digoxin accumulation, digoxin binding, and potassium influx.
After a certain period of time in erythrocytes incubated with ['H]digoxin (of sufficient concentration to occupy all of the glycoside-binding sites with [3H]digoxin), the amount of ['H]digoxin bound to the erythrocyte membrane and the amount taken up across the cell membrane into the cell will become constant.
That is, the system will reach a steady state and the rates at which ['H]digoxin molecules move from the intracellular fluid and from the erythrocyte membrane into the incubation solution will be equal to the rates at which ['H] digoxin molecules move from the incubation solution into the cell and onto the erythrocyte membrane, respectively. Addition of excess (at least 1000-fold) ouabain to the incubation solutions alters the system so that it is much more likely that a ['H]digoxin molecule, which dissociates from a membranebinding site, will be replaced by a ouabain molecule than by another ['H]digoxin molecule. The rate at which ['H]digoxin molecules are replaced by ouabain molecules is determined primarily by the rate at which ['H]-digoxin molecules dissociate from their binding sites. Furthermore, occupation of a glycoside-binding site by ouabain will not change potassium influx since once they are bound to the cell membrane, ouabain and digoxin are equipotent in terms of their inhibition of potassium influx (Fig. 5) . However, addition of excess ouabain does not alter the probability that a ['H]digoxin molecule, which leaves the intracellular fluid, will be replaced by another ['H]digoxin molecule since uptake of digoxin across the cell membrane into the cell is not altered by excess ouabain.
Under similar conditions, addition of excess digoxinspecific antibodies to the incubation medium will also result in a decrease in the number of [ 
